RNS Number : 1688A
GlaxoSmithKline PLC
02 October 2009
 





Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.


On 30 September 2009, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.41 per Ordinary share and $39.60 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2009 to 30 September 2009:


Non Executive Director

Ordinary Shares

American Depository 
Shares (ADSs)

Sir Christopher Gent

2,719.58


Prof. Sir Roy Anderson

528.810


Dr Stephanie Burns


330.08

Mr Lawrence Culp


330.08

Sir Crispin Davis

1,913.78


Sir Deryck Maughan


330.080

Mr James Murdoch

377.72


Dr Daniel Podolsky


424.39

Mr Tom de Swaan

528.81


Sir Robert Wilson

528.81



The Company and the Non-Executive Directors were informed of these allocations on 2 October 2009.


This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).


S M Bicknell

Company Secretary

2 October 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
 
 

RNS news service provided by Hemscott Group Limited.